Docusate Calcium — Veterinary Vademecum Drug Reference

Dosage & Administration Guidelines

Species	Route	Dose	Frequency	Duration & Clinical Notes
Dog	PO	50-100 mg per animal (or 2-5 mg/kg)	q12h to q24h	Duration: As needed until stool softens (usually 2-3 days) Notes: Administer with food and ensure adequate water intake. For megacolon, use in combination with other therapies.
Cat	PO	50 mg per cat (or 2-5 mg/kg)	q12h to q24h	Duration: As needed until stool softens (usually 2-3 days) Notes: May be given with food. Ensure adequate hydration. For megacolon, use as adjunctive therapy.
Horse	PO (via stomach tube or in feed)	2-5 mg/kg	q12h to q24h	Duration: Until impaction resolves (usually 2-5 days) Notes: Use with fluid therapy for impaction colic. Monitor for electrolyte imbalances.

Clinical Indications & Species Uses

General Indications

Constipation
Fecal softening

Dog (Canine)

Constipation
Fecal impaction
Megacolon (adjunctive therapy)
Post-surgical fecal softening

Cat (Feline)

Constipation
Fecal impaction
Megacolon (adjunctive therapy)
Hairball management (as part of therapy)

Horse (Equine)

Constipation
Impaction colic (adjunctive therapy)

Pharmacology & Mechanism of Action

Drug Class: Stool Softener (Laxative) | Pharmacological Group: Anionic Surfactant / Emollient Laxative

Mechanism of Action: Docusate calcium is an anionic surfactant that reduces the surface tension of fecal material, allowing water and lipids to penetrate and soften the stool. It also stimulates intestinal fluid and electrolyte secretion by increasing mucosal cAMP, which further promotes defecation. The drug acts primarily in the large intestine, facilitating easier passage of feces without stimulating peristalsis directly.

Pharmacodynamics: Docusate calcium exerts its effect locally in the gastrointestinal tract. It lowers the surface tension at the oil-water interface of fecal matter, promoting mixing of aqueous and fatty components. This results in softer, more easily passed stools. The onset of action is typically 24-72 hours after oral administration. It does not stimulate the intestinal smooth muscle directly, so it is not a true stimulant laxative.

⚡ Pharmacokinetics Summary

Absorption: Docusate calcium is minimally absorbed from the gastrointestinal tract. The small amount absorbed is metabolized and excreted in bile and urine.

Distribution: Systemic distribution is negligible due to poor absorption. The drug remains largely within the intestinal lumen.

Metabolism: The absorbed fraction undergoes hepatic metabolism, primarily via de-esterification and glucuronidation.

Excretion: The majority of the dose is excreted in feces as unchanged drug. The absorbed portion is excreted in bile and urine.

Half-Life: Not well defined due to minimal systemic absorption; local action predominates.

Bioavailability: Oral bioavailability is very low (<1%) due to poor absorption.

Protein Binding: Not applicable due to minimal systemic absorption.

Available Formulations & Strengths

Oral Capsule 50 mg, 100 mg, 240 mg (PO)

Oral Tablet 50 mg, 100 mg (PO)

Oral Syrup/Solution 20 mg/5 mL, 50 mg/5 mL (PO)

Contraindications & Clinical Warnings

Contraindications:

Intestinal obstruction
Fecal impaction with complete obstruction
Acute abdominal pain of unknown etiology
Nausea or vomiting
Hypersensitivity to docusate or any component
Concurrent use with mineral oil (risk of lipid pneumonia if aspirated)

Warnings & Clinical Precautions:

Use with caution in animals with renal impairment or electrolyte imbalances.
Do not administer concurrently with other laxatives unless directed by a veterinarian.
Ensure adequate hydration during therapy.
Prolonged use may lead to dependence or electrolyte disturbances.
Use with caution in debilitated or geriatric animals.
In horses, use with caution in cases of severe dehydration or cardiovascular compromise.

Adverse Effects & Reactions

Common:

Mild diarrhea
Abdominal cramping
Nausea (rare in animals)

Serious / Severe:

Electrolyte imbalance (with prolonged use)
Dehydration
Intestinal obstruction (if used inappropriately)

Rare:

Allergic reactions (rash, urticaria)
Aspiration pneumonia (if administered with mineral oil)

Key Drug Interactions

Interacting Drug / Class	Clinical Effect & Mechanism	Severity
Mineral oil	May increase risk of lipid pneumonia if aspirated; concurrent use not recommended.	High
Other laxatives (e.g., stimulant laxatives)	May increase risk of excessive diarrhea and electrolyte loss.	Moderate
Antacids containing aluminum or magnesium	May reduce the effectiveness of docusate.	Mild
Diuretics	May increase risk of electrolyte imbalance.	Moderate

Overdose & Toxicity Management

Signs of Toxicity:

Severe diarrhea
Dehydration
Electrolyte imbalances
Lethargy
Abdominal pain

Emergency Treatment Protocol: Discontinue the drug. Provide supportive care including fluid therapy to correct dehydration and electrolyte imbalances. Monitor serum electrolytes and renal function. In severe cases, hospitalization may be required.

Food Animal Withdrawal Times

Not approved for food animals; withdrawal times not established. Use in food animals is off-label and must follow appropriate withdrawal periods based on veterinary judgment.

Storage, Handling & Regulatory Information

Storage Temperature: Store at room temperature (20-25°C / 68-77°F)

Handling & Special Conditions: Keep container tightly closed. Protect from moisture.

Dispensing Status: Over-The-Counter (OTC)

Approval Status: Approved for human use; not specifically approved for veterinary use, but widely used in veterinary medicine.

Extra-Label (Off-Label) Use: In the US, extra-label use in food animals is prohibited unless under a valid VCPR and with appropriate withdrawal times. In companion animals, extra-label use is common.

Clinical Pearls & Practice Notes

💡 Clinical Insights: Docusate calcium is a safe and effective stool softener for the management of constipation and fecal impaction in dogs, cats, and horses. It is not a stimulant laxative and should be used as an adjunct to adequate hydration and dietary management. In cases of megacolon, it may be used long-term but should be combined with other therapies such as dietary fiber, prokinetic agents, and enemas. For horses with impaction colic, docusate calcium can be administered via nasogastric tube along with fluid therapy. Always ensure the animal is well-hydrated to achieve optimal effect. Monitor for adverse effects, especially with prolonged use.

References & Literature

📚 Plumb's Veterinary Drug Handbook
📚 Papich Veterinary Pharmacology and Therapeutics
📚 Compendium of Veterinary Products (CVP)